Sort   by:  
 Page size 
UnknownVariability and correlations of synthetic chemicals in urine from a New York City-based cohort of pregnant women.
Not available
S-EPMC9600950 | biostudies-literature
ProteomicsAn integrated multi-omic workflow reveals markers of host-microbe dynamics in clinical cystic fibrosis samples
Airway microbiota composition correlates with cystic fibrosis (CF) progression, however, microbial drivers of disease remain unclear. MS-based metaproteomics of bronchoalveolar lavage fluid (BALF) offers insights into both host and microbe dynamics and potential interactions. However, detection of...
ORGANISM(S): Homo sapiens (Human) 
2024-06-25 | PXD041457 | Pride
Human Faims Cystic fibrosis Bronchoalveolar lavage Bal Cf Prm Immune Microbe Mass spectrometry Lung Infection 
Unknown100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.
Not available
S-EPMC7613219 | biostudies-literature
UnknownA novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action.
Not available
S-EPMC4585672 | biostudies-literature
UnknownSex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.
Not available
S-EPMC8458480 | biostudies-literature
UnknownA prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
Not available
S-EPMC10195122 | biostudies-literature
UnknownUrinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program.
Not available
S-EPMC11829711 | biostudies-literature
UnknownHUWE1 variants cause dominant X-linked intellectual disability: a clinical study of 21 patients.
Not available
S-EPMC5788272 | biostudies-literature
UnknownCharacteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.
Not available
S-EPMC7501875 | biostudies-literature
UnknownCOmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Not available
S-EPMC12315800 | biostudies-literature
Sort   by:  
 Page size